Andrew Lerner, Ph.D.

Patent Lead
andrew@rockridgelaw.com

• National Institutes of Health (NIH) RADx Faculty Member
• B.S., UC Berkeley; Ph.D., UNC Chapel Hill
• Veteran U.S.M.C., Russian cryptologist

Background

Andrew Lerner, Ph.D. is the Patent Lead at Rockridge Venture Law®, a Certified B Corp earning Best For The World honors. Andrew is a registered patent agent and his practice areas include clearance & patentability analyses, patent prosecution, and due diligence; strategic IP portfolio development; and IP diligence for life science venture funds.

Andrew’s technical focus areas include:

  • Antibodies
  • Biosensors
  • Biological Materials
  • Cell Lines
  • Delivery Systems
  • Nucleic Acids / DNA / RNA
  • Protein Synthesis
  • Screening Assays
  • Vectors

Andrew is also a faculty member of the NIH RADx Program accelerating novel point-of-care diagnostics.

Andrew has supported faculty, researchers, and staff involved in innovation and commercialization at Duke University Innovation & Entrepreneurship and the University of North Carolina, Chapel Hill Eshelman Institute for Innovation. He has led IP activities for life science and biotechnology seed funding for early-stage technologies and ideas and has advised academic translational researchers across broad disciplines, including biomedical engineering, pharmacology & cancer biology, and medicine.

As an entrepreneur, Andrew Lerner has advised startups developing bispecific antibody therapeutics and testing entire communities for COVID-19. Andrew has served as a reviewer for proposals for the NSF SBIR Program and other seed stage funds, and he regularly advises entrepreneurs as a mentor through Veterati, a platform that connects mentors with Service Members, Veterans, and Military Spouses.

Andrew’s academic research has focused on engineering novel proteins to study fundamental mechanisms of epigenetic regulation at UNC Chapel Hill, as well as study of protein regulatory mechanisms at the University of California, Berkeley.

Andrew holds a Ph.D. in Biochemistry & Biophysics from the University of North Carolina, Chapel Hill, and earned a Graduate Certificate in Technology Commercialization and Entrepreneurship through coursework at the UNC Kenan-Flagler Business School. He holds a B.S. in Chemistry from the University of California, Berkeley, and an A.A. in Russian from the Defense Language Institute Foreign Language Center, Monterey, CA.

A United States Marine Corps veteran, Andrew deployed overseas and held a top-secret security clearance while serving as a signals intelligence analyst with the National Security Agency.

Email Andrew or schedule time with him through Calendly to discuss how he can benefit your technology development needs.

RVL articles by Andrew:

5 Interesting IP Cases of 2020

Patenting Biologics: Observations on Patenting Antibody Therapeutics with the Cat in the Hat

Why, When, and How Should I File a Patent Application?

5 Interesting IP Cases in 2019 and Why They Matter for 2020

Patent Trolling in the Time of COVID-19

Presentations & Publications